>
>
>
Valuation of Patents and Emerging Technologies

Valuation of Patents and Emerging Technologies

$1,195

- +

The overwhelming value of most early-stage companies resides in their intellectual assets. However, senior managers of such companies usually have no idea how to value their inventions. This is unfortunate as the inability to value intangible assets puts companies at a severe disadvantage when trying to monetize their discoveries through capital raises, licensing, joint-ventures or sales.

Inventors, investors, patentees, licensors and licensees must be able to articulate the value of their patents and emerging technologies. Otherwise, they will never receive the valuations that they deserve.

This seminar provides an in-depth review of more than 20 valuation methodologies such as:

  • •Cost Method
  • •Market Method
  • •Income Method
  • •Decision Trees
  • •Competitive Advantage Valuation
  • •25% Rule
  • •The Monte Carlo Method
  • •Real Options Method
  • •Binomial Method
  • •Probability Weighted Expected Return Method
  • •Relief from Royalty Method
  • •Excess Earnings Method
  • •Markov Chains
  • •Bayesian Analysis
  • •Probabilistic Methodologies

Case studies / exercises relating to the following are among those reviewed in the course:

  • •Acquisition Comparables
  • •Stock Price Indication Methods
  • •Venture Funding Comparables
  • •Bayesian Analysis
  • •Probabilistic Methodologies
  • •Cross-Licensing

Patent Valuation Gauntlet (PVG)

This seminar will introduce you to the Patent Valuation Gauntlet (PVG). In deriving the value of a patent, PVG takes into account commercial value, assertion value, blocking value, cross-licensing value, reputational value as well as patent invalidity risks and design around risks.

The PVG worksheet contains more than 900 issues that should be considered when calculating the value of a patent.

Additional Valuation Considerations

  • •Citation Analysis
  • •Enforceability
  • •Current Impact
  • •Claim Scope Breadth
  • •Technology Strength
  • •Validity Confidence
  • •Research Intensity
  • •Litigation Avoidance
  • •Science Strength
  • •Partnering Licensing Potential
  • •Innovation Cycle Time
  • •Technology Cogency

Excel sheets with the more than 40 valuation methodologies are included with your registration.

Bonus Book

Attendees of live courses receive a handbook which sells for $295 for FREE.
This Valuation of Patents and Emerging Technologies Handbook includes over 300 slides, articles and presentations which focus on all aspects of valuing early-stage technologies. Over 40 valuation methodologies are illustrated as well as dozens of patent valuation metrics.


This course is also offered on a custom basis. The content can be customized to meet your company’s specific needs and can also be delivered exclusively to your employees at your offices.

Further Information

Contact: Neomi Barazani

Phone:
609-919-1895
ext. 100

Email:
neomi@cpva.info

Course Length:

Approx. 8 hours

Course Schedule:

Webinars: This rate is for one participant. Distribution of login information is prohibited. Site licenses for up to five participants are available for $3,295.
To arrange a site license, please contact Neomi Barazani at 609-919-1895 ext. 100 or
neomi@cpva.info.

Seating is Limited to 15 per session
Register online or by contacting
Registration Coordinator,
at 609-919-1895 ext. 100 or
neomi@cpva.info

Requests to cancel your registration must be made in writing one month before the date of the seminar. Your refund will reflect a $95 processing fee. No refunds will be granted within one month of the course for which you are enrolled. You may send a substitute for an additional $55 processing fee.

David Wanetick

David Wanetick, Chief Executive Officer, IncreMental Advantage

About the Lead Instructor:

David Wanetick, Chief Executive Officer, IncreMental Advantage

David Wanetick is the CEO of IncreMental Advantage, a valuation firm internationally recognised for its expertise in valuing patents, intangible assets (including data, databases, trade secrets, trademarks and copyrights), emerging technologies, and early-stage companies.

David’s valuation reports support major business transactions, including capital raises, company acquisitions and sales, patent portfolio sales, and licensing agreements. These reports help determine the value of transactions worth tens or even hundreds of millions of dollars.

IncreMental Advantage also provides valuation and damages reports for disputes, divorces, partnership disagreements, impairment charges, bankruptcy proceedings, grant applications, loan collateralisation, and the transfer of patent assets between companies and jurisdictions.

Its clients range from start-ups to Fortune 100 companies, as well as technology transfer offices, incubators, law firms, venture capital firms, and private equity investors.

Certified Patent Valuation Analyst

David developed and leads the Certified Patent Valuation Analyst (CPVA) designation, a globally recognised professional course that he has taught across numerous countries, including India, Israel, Thailand, Singapore, China, Hong Kong, Malaysia, Dubai, the Philippines, France, the Netherlands, Spain, the United Kingdom, Belgium, Denmark, Germany, and Canada.

Course participants include intellectual property asset managers, licensing executives, technology transfer professionals, patent lawyers, patent examiners, and inventors.

More than 250 testimonials from course participants are available here.

David has also published more than 20 articles on patent valuation, available here. His work on valuing patents, early-stage technologies, and negotiating licensing agreements has appeared in Intellectual Asset Management, CEO Magazine, Licensing Journal, Willamette Insights, Valuation Strategies, IP Frontline, Technology Transfer Tactics, and Inventor’s Digest, among other publications.

Investment Banking

David also serves as a Managing Director at Merit Investment Bank, a leading FINRA-regulated investment bank specialising in the lower middle market.

Author and Media Contributions

David is the author of seven internationally acclaimed books, including the only two books dedicated to unveiling Industry Analysis.

His more recent publications include:

David has appeared as a guest on CNBC, Bloomberg, and CNNfn.

He has also been quoted in prominent publications, including The Wall Street Journal, Barron’s, and Investor’s Business Daily, as well as numerous other newspapers, blogs, and magazines across the United States.

SKU: Valuation of Patents and Emerging Technologies Category:

Start typing and press Enter to search

Shopping Cart

No products in the cart.